These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9710083)

  • 1. A subject of ongoing investigation: can exogenous surfactant be used to treat ARDS?
    Serna D; Brenner M; Chen JC
    Crit Care Med; 1998 Aug; 26(8):1307-8. PubMed ID: 9710083
    [No Abstract]   [Full Text] [Related]  

  • 2. Bronchoscopic instillation of surfactant in acute respiratory distress syndrome.
    Nakamura CT; Ripka JF; McVeigh K; Kapoor N; Keens TG
    Pediatr Pulmonol; 2001 Apr; 31(4):317-20. PubMed ID: 11288218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous surfactant and positive end-expiratory pressure in the treatment of endotoxin-induced lung injury.
    Lutz CJ; Picone A; Gatto LA; Paskanik A; Landas S; Nieman GF
    Crit Care Med; 1998 Aug; 26(8):1379-89. PubMed ID: 9710098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant replacement in the treatment of sepsis-induced adult respiratory distress syndrome in pigs.
    Nieman GF; Gatto LA; Paskanik AM; Yang B; Fluck R; Picone A
    Crit Care Med; 1996 Jun; 24(6):1025-33. PubMed ID: 8681569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adjunctive pharmacotherapy for acute respiratory distress syndrome].
    Hecker M; Weigand MA; Mayer K
    Dtsch Med Wochenschr; 2017 Jan; 142(2):96-101. PubMed ID: 28114714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous surfactant and alveolar recruitment in the treatment of the acute respiratory distress syndrome.
    Rodríguez-Moya VS; Gallo-Borrero CM; Santos-Áreas D; Prince-Martínez IA; Díaz-Casañas E; López-Herce Cid J
    Clin Respir J; 2017 Nov; 11(6):1032-1039. PubMed ID: 26881996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved oxygenation by nitric oxide is enhanced by prior lung reaeration with surfactant, rather than positive end-expiratory pressure, in lung-lavaged rabbits.
    Gommers D; Hartog A; van 't Veen A; Lachmann B
    Crit Care Med; 1997 Nov; 25(11):1868-73. PubMed ID: 9366772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant for acute respiratory distress syndrome.
    Jobe AH; Ikegami M
    Adv Intern Med; 1997; 42():203-30. PubMed ID: 9048120
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of surfactant in children with acute respiratory distress syndrome: efficacy in terms of oxygenation, ventilation and mortality.
    Yapicioğlu H; Yildizdaş D; Bayram I; Sertdemir Y; Yilmaz HL
    Pulm Pharmacol Ther; 2003; 16(6):327-33. PubMed ID: 14580923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled epoprostenol in ARDS.
    Modrykamien AM
    Respir Care; 2014 Aug; 59(8):1312-3. PubMed ID: 25233520
    [No Abstract]   [Full Text] [Related]  

  • 11. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group.
    Anzueto A; Baughman RP; Guntupalli KK; Weg JG; Wiedemann HP; Raventós AA; Lemaire F; Long W; Zaccardelli DS; Pattishall EN
    N Engl J Med; 1996 May; 334(22):1417-21. PubMed ID: 8618579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome.
    Kesecioglu J; Beale R; Stewart TE; Findlay GP; Rouby JJ; Holzapfel L; Bruins P; Steenken EJ; Jeppesen OK; Lachmann B
    Am J Respir Crit Care Med; 2009 Nov; 180(10):989-94. PubMed ID: 19713451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome.
    Zhu GF; Sun B; Niu SF; Cai YY; Lin K; Lindwall R; Robertson B
    Am J Respir Crit Care Med; 1998 Aug; 158(2):437-43. PubMed ID: 9700118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant replacement for respiratory failure: lessons from the neonate.
    Gregory GA; Phibbs RH
    Anesth Analg; 1993 Mar; 76(3):465-6. PubMed ID: 8452250
    [No Abstract]   [Full Text] [Related]  

  • 15. Surfactant: current and potential therapeutic application in infants and adults.
    Lewis J; Veldhuizen RA
    J Aerosol Med; 1996; 9(1):143-54. PubMed ID: 10160204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surfactant replacement therapy increases life-span of patients with acute respiratory distress syndrome].
    Potapov AL; Novikov NIu; Tumanskiĭ VA; Babanin AA
    Klin Khir; 2013 Feb; (2):57-9. PubMed ID: 23705485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on ARDS: beyond the low tidal volume.
    Dernaika TA; Keddissi JI; Kinasewitz GT
    Am J Med Sci; 2009 May; 337(5):360-7. PubMed ID: 19440058
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adult respiratory distress syndrome].
    Draganov V; Lazarov S
    Vutr Boles; 2000; 32(3):19-28. PubMed ID: 11688318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tetracycline analog improves acute respiratory distress syndrome survival in an ovine model.
    Zhou X; Wang D; Ballard-Croft CK; Simon SR; Lee HM; Zwischenberger JB
    Ann Thorac Surg; 2010 Aug; 90(2):419-26. PubMed ID: 20667323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing efficacy of exogenous surfactant in acute lung injury.
    Lewis JF; Veldhuizen RA
    Biol Neonate; 1995; 67 Suppl 1():48-60. PubMed ID: 7647158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.